Literature DB >> 25148758

Quality of life measures in Italian neurosurgical patients: validity of the EUROHIS-QOL 8-item index.

Silvia Schiavolin1, Rui Quintas, Paolo Ferroli, Francesco Acerbi, Stefano Brock, Alberto Cusin, Marco Schiariti, Sergio Visintini, Morgan Broggi, Matilde Leonardi, Alberto Raggi.   

Abstract

PURPOSE: To assess the validity, reliability and factor structure of the Italian version of the EUROHIS-QOL (European Health Interview Survey-Quality of Life) 8-item index in patients who are potential candidates for neurosurgical procedures.
METHODS: Cross-sectional study. Patients completed the EUROHIS-QOL 8-item index, a disability and general well-being questionnaire; the Karnofsky performance status scale (KPS) was used as a general measure of functional status. Factor analysis was used to confirm the one-factor structure of the EUROHIS-QOL 8-item index. Reliability was measured using Cronbach's alpha coefficient, item-total correlation and inter-item correlation. Construct validity was assessed with Pearson's coefficient (expected to be below 0.70) and known-group analysis, dividing patients between those KPS >90 and KPS ≤90 (the latter expected to report lower QoL).
RESULTS: The one-factor structure was partly confirmed, with two items having low loadings. Cronbach's alpha was 0.78; item-total correlations were below 0.70; and average inter-item correlation was 0.309. Correlations were all significant and moderate; known-group analysis shows that QoL scores were lower in patients with active symptoms (KPS ≤90).
CONCLUSIONS: Our findings partly confirm the factor structure and reliability of the EUROHIS-QOL 8-item index, which suggests that it may be a useful and straightforward quality of life measurement technique in neurosurgical departments.

Entities:  

Mesh:

Year:  2014        PMID: 25148758     DOI: 10.1007/s11136-014-0784-7

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  16 in total

1.  The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group.

Authors:  S M Skevington; M Lotfy; K A O'Connell
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

Review 2.  Review on quality of life issues in patients with primary brain tumors.

Authors:  Martin J B Taphoorn; Eefje M Sizoo; Andrew Bottomley
Journal:  Oncologist       Date:  2010-05-27

3.  The EUROHIS-QOL 8-item index: psychometric results of a cross-cultural field study.

Authors:  Silke Schmidt; Holger Mühlan; Mick Power
Journal:  Eur J Public Health       Date:  2005-09-01       Impact factor: 3.367

Review 4.  Microscope in modern spinal surgery: advantages, ergonomics and limitations.

Authors:  Omprakash Damodaran; Jenny Lee; Gabriel Lee
Journal:  ANZ J Surg       Date:  2013-01-20       Impact factor: 1.872

Review 5.  Spinal surgery and neurosurgeon: quo vadis?

Authors:  A Kanat; U Yazar
Journal:  J Neurosurg Sci       Date:  2013-03       Impact factor: 2.279

Review 6.  Cerebrovascular neurosurgery 2011.

Authors:  Bradley A Gross; Rose Du
Journal:  J Clin Neurosci       Date:  2012-08-11       Impact factor: 1.961

Review 7.  Transcranial minimally invasive neurosurgery for tumors.

Authors:  Mark Garrett; Giacomo Consiglieri; Peter Nakaji
Journal:  Neurosurg Clin N Am       Date:  2010-08-30       Impact factor: 2.509

Review 8.  Quality of life after stroke: the importance of a good recovery.

Authors:  Francisco Javier Carod-Artal; José Antonio Egido
Journal:  Cerebrovasc Dis       Date:  2009-04-03       Impact factor: 2.762

9.  The EUROHIS-QOL 8-item index: comparative psychometric properties to its parent WHOQOL-BREF.

Authors:  Neusa Sica da Rocha; Mick J Power; Donald M Bushnell; Marcelo P Fleck
Journal:  Value Health       Date:  2012-02-09       Impact factor: 5.725

Review 10.  Intraoperative MR-guided neurosurgery.

Authors:  Walter A Hall; Charles L Truwit
Journal:  J Magn Reson Imaging       Date:  2008-02       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.